Notice: This article has been formally RETRACTED by the publisher. The validity of the data and conclusions presented herein should be treated with extreme caution.
Abstract
Optically active nanostructures consisting of organic compounds and metallic support have shown great promise in phototherapy due to their increased light absorption capacity and high energy conversion. Herein, we conjugated chlorophyll (Chl) to vanadium carbide (V2C) nanosheets for combined photodynamic/photothermal therapy (PDT/PTT), which reserves the advantages of each modality while minimizing the side effects to achieve an improved therapeutic effect. In this system, the Chl from Leptolyngbya JSC-1 extracts acted as an efficient light-harvest antenna in a wide NIR range and photosensitizers (PSs) for oxygen self-generation hypoxia-relief PDT. The available large surface of two-dimensional (2D) V2C showed high Chl loading efficiency, and the interaction between organic Chl and metallic V2C led to energy conversion efficiency high to 78%. Thus, the Chl/V2C nanostructure showed advanced performance in vitro cell line killing and completely ablated tumors in vivo with 100% survival rate under a single NIR irradiation. Our results suggest that the artificial optical Chl/V2C nanostructure will benefit photocatalytic tumor eradication clinic application.
Introduction
Precision in cancer treatment remains a significant challenge, with traditional methods often limited by systemic side effects. Phototherapy, encompassing Photodynamic Therapy (PDT) and Photothermal Therapy (PTT), offers a minimally invasive alternative. However, PDT's efficacy is frequently hampered by tumor hypoxia, while PTT requires highly efficient light-to-heat conversion agents. This study reports the development of a hybrid nanostructure ($Chl/V_2C$) designed to overcome these hurdles by conjugating natural chlorophyll (Chl) onto vanadium carbide ($V_2C$) nanosheets.
Methods and Materials
The researchers employed a "green" synthesis approach for $V_2C$ nanosheets (MXenes) using algae-mediated processes to enhance biocompatibility. Chlorophyll was extracted from the cyanobacterium Leptolyngbya JSC-1 and loaded onto the $V_2C$ nanosheets via sonication. The resulting $Chl/V_2C$ system was designed for dual-laser irradiation: a 670 nm wavelength to trigger Chl-mediated PDT and an 808 nm wavelength to activate $V_2C$-mediated PTT. Efficacy was evaluated across multiple cell lines (MCF-7, HeLa, A549) and in vivo using Balb/c nude mice with tumor xenografts.
Results and Key Insights
The $Chl/V_2C$ nanostructure demonstrated a high photothermal conversion efficiency (PTCE) of 78%, significantly outperforming standard 2D agents like pure $V_2C$ (~47%) or $MoS_2$ (~24%). A key claim is the role of Chl as a light-harvesting antenna capable of facilitating water splitting to generate oxygen locally, thereby mitigating tumor hypoxia and enhancing PDT effectiveness.
In vivo studies reported complete tumor ablation within 12 days under dual NIR irradiation, with a 100% survival rate in the treatment group. In vitro results showed a reduction in cell viability to approximately 1% using the synergistic approach, compared to significantly higher survival rates with individual modalities. The nanostructure also exhibited high photothermal stability over multiple laser cycles and favorable biodistribution due to the Enhanced Permeation and Retention (EPR) effect.
Discussion and Limitations
While the reported results suggest a highly effective "green" theranostic platform, the formal retraction of this article necessitates critical skepticism regarding the data's integrity. Beyond the retraction, clinical translation faces typical challenges, including the limited penetration depth of NIR light for deep-seated tumors and the complexities of long-term metabolic fate in humans. The proposed mechanism for Chl-mediated oxygen generation in vivo also requires further independent validation to ensure its feasibility in complex biological environments.
Summary updated